Thomas W. Dubensky, Chief Scientific Officer at ADURO BIOTECH, INC. (ADRO), sold 50,000 shares at $11.02 ($567K) on 2017-07-03, disclosed to the SEC on 2017-07-06.
Scheduled sale ($567k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.02 | 11,800 | $130K | 22.9% |
| 2 | $11.46 | 33,688 | $386K | 68.1% |
| 3 | $11.23 | 4,512 | $51K | 8.9% |
| Total | $11.34 avg | 50,000 | $567K | 100% |
| Filing → |
| ADRO | SELL | 2017-06-05 | $1.4M | — | Filing → |
| ADRO | SELL | 2017-05-15 | $57K | — | Filing → |
| ADRO | SELL | 2017-03-10 | $274K | — | Filing → |